Nuwiq 250IU Powder for Solution for Injection

Manufacturer
OCTAPHARMA AB(SWEDEN)

Registraction Number
MAL20026053AZ

Content:
Nuwiq 250 IU Powder for Solution for Injection contains Simoctocog Alfa (recombinant human coagulation factor VIII). Each vial nominally contains 250 IU of factor VIII.
Indications:

• Hemophilia A: It is used to replace the missing or deficient factor VIII, helping to control and prevent bleeding episodes.
• On-demand treatment: Controls bleeding episodes as they occur.
• Perioperative management: Manages bleeding during and after surgery.
• Routine prophylaxis

• On-demand treatment: The dose is determined based on body weight and the severity of the bleeding episode. Your doctor will provide specific instructions.
• Prophylaxis: Typical dose is 30-40 IU/kg every other day for adults and adolescents, and 30-50 IU/kg every other day or three times per week for children.

1. Reconstitution:
   • Use the provided solvent to dissolve the powder in the vial.
   • Gently swirl the vial until the powder is fully dissolved. Do not shake.
2. Injection:
   • Draw the solution into the syringe provided.
   • Administer intravenously (IV) over several minutes, as directed by your healthcare provider.
   • Rotate injection sites to prevent complications.